Login / Signup
Considerations for SGLT2 inhibitor use in post-transplantation diabetes.
Manfred Hecking
Trond Jenssen
Published in:
Nature reviews. Nephrology (2020)
Keyphrases
</>
type diabetes
cardiovascular disease
glycemic control
cell therapy
adipose tissue
mesenchymal stem cells